The history of Sildenafil presents a complex picture for shareholders. While the initial introduction generated massive profits, the expiration of its intellectual property protection opened the floodgates to off-brand https://haimazwbb101125.post-blogs.com/62692040/the-copyright-and-big-pharma-a-risky-investment